Beyond Cytokinesis: the Emerging Roles of CEP55 in Tumorigenesis

Total Page:16

File Type:pdf, Size:1020Kb

Beyond Cytokinesis: the Emerging Roles of CEP55 in Tumorigenesis Oncogene (2016) 35, 683–690 © 2016 Macmillan Publishers Limited All rights reserved 0950-9232/16 www.nature.com/onc REVIEW Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis J Jeffery1, D Sinha1,2, S Srihari3, M Kalimutho1 and KK Khanna1 CEP55 was initially identified as a pivotal component of abscission, the final stage of cytokinesis, serving to regulate the physical separation of two daughter cells. Over the past 10 years, several studies have illuminated additional roles for CEP55 including regulating the PI3K/AKT pathway and midbody fate. Concurrently, CEP55 has been studied in the context of cancers including those of the breast, lung, colon and liver. CEP55 overexpression has been found to significantly correlate with tumor stage, aggressiveness, metastasis and poor prognosis across multiple tumor types and therefore has been included as part of several prognostic ‘gene signatures’ for cancer. Here by discussing in depth the functions of CEP55 across different effector pathways, and also its roles as a biomarker and driver of tumorigenesis, we assemble an exhaustive review, thus commemorating a decade of research on CEP55. Oncogene (2016) 35, 683–690; doi:10.1038/onc.2015.128; published online 27 April 2015 INTRODUCTION CG-NAP and Pericentrin B.8 Like many other centrosomal A decade ago, we identified and characterized CEP55 (also proteins, CEP55 is a highly coiled-coil protein (Figures 1a).1 The known as c10orf3 and FLJ10540) as a centrosome-and midbody- N-terminus contains a homodimerization domain, while a hinge associated protein and a key regulator of cytokinesis.1 Subsequent region in the coiled coil has been termed the ESCRT and ALIX- studies described how CEP55 might cooperate with members of binding region (EABR) and is critical to its role in cytokinesis endosomal sorting complex required for transport (ESCRT) (Figures 1a and b).4,9 The C-terminus of the protein targets it to 2–4 machinery to constrict intracellular bridge to allow abscission. both the centrosome and the midbody.1 CEP55 not only localizes More recently, we and others have deciphered additional roles for primarily to the pericentriolar matrix but also is associated with CEP55 in regulating the PI3K/AKT pathway and stemness as well the mother centriole. It does not require the microtubules for its as in promoting tumorigenesis. Together, these studies have centrosomal localization. CEP55 interacts with the pericentriolar fi unveiled critical functions of CEP55 outside cytokinesis, rede ning matrix proteins CG-NAP and pericentrin B but is not required the paradigm of CEP55 action in cells. Herein, the pleiotropic roles for microtubule nucleation in interphase cells or for the of CEP55 including its function in cytokinesis and the implications localization of CG-NAP or pericentrin B to the centrosome.1,9 for human tumorigenesis are comprehensively discussed. CEP55 remains on the centrosome throughout the cell cycle and is recruited to the mitotic spindle during mitosis.9 Consistent fi CEP55 IN CYTOKINESIS with this, CEP55 has been identi ed in the human mitotic spindle proteome.10 CEP55 also localizes to the central spindle during fi Cytokinesis is the nal stage of cell division that divides the anaphase and the midbody during cytokinesis.1,11 CEP55 is cytoplasm equally amongst two daughter cells. After the DNA is reported to have microtubule-bundling activity in vitro,11 separated at opposite ends of the cell, the plasma membrane fi 5 although the signi canceofthisiscurrentlyunclear. begins to ingress in the middle where the midbody forms. During The localization of CEP55 to the central spindle and midbody is cytokinesis there is a sequential recruitment of protein complexes mediated through an interaction with the centralspindlin to the midbody, resulting in a cytokinetic bridge constricting on complex (comprised of MKLP1 and MgcRacGAP) by direct either side of the midbody and the severing of microtubules contact with MKLP1.11 The importance of this association was contained within the bridge. During abscission, the final stage of cytokinesis, the cytokinetic bridge tears at the constriction site, highlighted in MKLP1-depleted cells, where CEP55 could not thus providing physical separation between the daughter cells.6 localize to the midbody. The breast and ovarian cancer We initially described CEP55 as a centrosome- and midbody- susceptibility gene, BRCA2, was also recently shown to modulate 12 associated protein of ~ 55 kDa in size, which spans 464 amino recruitment of CEP55 to the midbody. Syntaxin16, a protein acids (Figure 1a).1 The centrosome is comprised of two centrioles involved in membrane fusion, has been shown to regulate surrounded by a cloud of electron-dense material known as the cytokinesis through its indispensable role in the recruitment of pericentriolar matrix.7 The pericentriolar matrix is comprised of recycling endosomes, exocyst components and CEP55 to the a number of coiled-coil proteins including key structural proteins midbody.13 1Signal Transduction Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; 2School of Natural Sciences, Griffith University, Brisbane, Queensland, Australia and 3Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia. Correspondence: Professor KK Khanna, Signal Transduction Laboratory, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, Queensland, Australia. E-mail: [email protected] Received 25 February 2015; revised 16 March 2015; accepted 16 March 2015; published online 27 April 2015 CEP55 and cancer J Jeffery et al 684 Figure 1. The role of CEP55 in cytokinesis. (a) Diagramatic representation of CEP55 and its domains. A coiled coil spans most of the protein, with a hinge region containing the ESCRT and ALIX-binding region (EABR). The N-terminal coiled-coil region (CC1) contains a homodimerization region (white dotted region), while the C-terminus (colored blue) targets CEP55 to the centrosome and midbody. This region is phosphorylated on S425, S428 and S436 during mitosis (red circles). (b) The structure of CEP55 complexes at the midbody. Each CEP55 homodimer can bind one molecule of either ALIX or TSG101 via its EABR domain. ALIX can then recruit ESCRT-III complexes directly, whereas TSG101 recruits ESCRT-III complexes via the recruitment of ESCRT-1. (c) The recruitment of ESCRT-III complexes in a CEP55-dependent manner promotes the formation of 17nm ESCRT-III filaments (pink), which creates a constriction site. ESCRT-III complexes then recruit Spastin to cleave the microtubules (orange). CEP55 recruits downstream machinery to the midbody Recently, BRCA2 has been reported to promote the ability of CEP55 is critical for correct midbody assembly and CEP55- CEP55 to recruit TSG101 and ALIX to the midbody independent of 12 depleted cells display an abnormal midbody structure with no its function in DNA repair, although the involvement of BRCA2 in 16 midbody visible under light microscopy.11 CEP55 targets cytokinesis remains controversial. Similarly, it is contentious a number of structural and regulatory proteins required for whether CEP55 has a more universal role in the regulation of completion of cytokinesis to the midbody including Aurora B, cytokinesis in mammalian cells as human embryonic kidney cells 14 MKLP2, PRC1, ECT2, Anillin and Syntaxin 2,11 demonstrating that (HEK293) continue to divide following CEP55 depletion. Addi- CEP55 is indispensable for midbody structure maintenance. tional work is required to discern whether this role is direct CEP55 also orchestrates final stage of abscission. During (by facilitating the actual abscission process) or indirect abscission, CEP55 at midbody recruits proteins that are directly (by regulating the recruitment of proteins involved in vesicular involved in the membrane fission (Tumor-susceptibility gene 101 trafficking). (TSG101) and ALG2-interacting protein X (ALIX)) and fusion events (Endobrevin) (Figures 1b and c).2,14 Centriolin, another centroso- The structure of CEP55/ESCRT complexes at the midbody mal protein, also recruits fission and fusion proteins by a distinct CEP55 complex formation with ALIX and TSG101 is required to 11,15 but parallel pathway. TSG101 is a component of ESCRT-I, while allow recruitment of ESCRT complexes to the midbody, which ALIX is an ESCRT-III associated protein.2 Both TSG101 and ALIX facilitate the membrane fission events necessary to create localize to centrosomes and have well-described functions in separation of the two daughter cells.2,14 Although there are retroviral budding as well as the membrane fission events of multiple ESCRT complexes (known as 0, I, II and III), ESCRT-III is the cytokinesis.2,14 Depletion of TSG101 or ALIX results in defective most critical for cytokinesis, forming long filamentous structures cytokinesis, which is reminiscent of the phenotype observed in which create the constriction site.2,14,17 ALIX is able to recruit CEP55-depleted cells with an increased proportion of multi- ESCRT-III directly, whereas TSG101 recruits ESCRT-I, which in turn nucleated cells and/or cells arrested at midbody stage.2 Notably, recruits ESCRT-III (Figure 1b).2,14 unlike TSG101 and ALIX viral budding is unaffected by depletion CEP55 is a highly coiled-coil protein which homodimerizes.9 of CEP55, indicating that CEP55 might act as an adaptor rather Initially, CEP55 was proposed to comprise of two coiled-coil than a component of the core ESCRT pathway to promote regions joined by a hinge
Recommended publications
  • Title a New Centrosomal Protein Regulates Neurogenesis By
    Title A new centrosomal protein regulates neurogenesis by microtubule organization Authors: Germán Camargo Ortega1-3†, Sven Falk1,2†, Pia A. Johansson1,2†, Elise Peyre4, Sanjeeb Kumar Sahu5, Loïc Broic4, Camino De Juan Romero6, Kalina Draganova1,2, Stanislav Vinopal7, Kaviya Chinnappa1‡, Anna Gavranovic1, Tugay Karakaya1, Juliane Merl-Pham8, Arie Geerlof9, Regina Feederle10,11, Wei Shao12,13, Song-Hai Shi12,13, Stefanie M. Hauck8, Frank Bradke7, Victor Borrell6, Vijay K. Tiwari§, Wieland B. Huttner14, Michaela Wilsch- Bräuninger14, Laurent Nguyen4 and Magdalena Götz1,2,11* Affiliations: 1. Institute of Stem Cell Research, Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany. 2. Physiological Genomics, Biomedical Center, Ludwig-Maximilian University Munich, Germany. 3. Graduate School of Systemic Neurosciences, Biocenter, Ludwig-Maximilian University Munich, Germany. 4. GIGA-Neurosciences, Molecular regulation of neurogenesis, University of Liège, Belgium 5. Institute of Molecular Biology (IMB), Mainz, Germany. 6. Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas and Universidad Miguel Hernández, Sant Joan d’Alacant, Spain. 7. Laboratory for Axon Growth and Regeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. 8. Research Unit Protein Science, Helmholtz Centre Munich, German Research Center for Environmental Health, Munich, Germany. 9. Protein Expression and Purification Facility, Institute of Structural Biology, Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany. 10. Institute for Diabetes and Obesity, Monoclonal Antibody Core Facility, Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany. 11. SYNERGY, Excellence Cluster of Systems Neurology, Biomedical Center, Ludwig- Maximilian University Munich, Germany. 12. Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, USA 13.
    [Show full text]
  • Bioinformatics Identi Cation of Prognostic Factors Associated With
    Bioinformatics Identication of Prognostic Factors Associated with Breast Cancer Ying Wei Sichuan University https://orcid.org/0000-0001-8178-4705 Shipeng Zhang College of Pharmacy, North Sichuan Medical College Li Xiao West China School of Basic Medical Sciences and Forensic Medicine Jing Zou West China School of Basic Medical Sciences and Forensic Medicine Yingqing Fu West China School of Basic Medical Sciences and Forensic Medicine Yi Ye West China School of Basic Medical Sciences and Forensic Medicine Linchuan Liao ( [email protected] ) West China School of Basic Medical Sciences and Forensic Medicine https://orcid.org/0000-0003-3700-8471 Research Keywords: Breast cancer, Differentially expressed genes, miRNAs, Transcription factors, Bioinformatic analysis Posted Date: December 2nd, 2020 DOI: https://doi.org/10.21203/rs.3.rs-117477/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/23 Abstract Background: Breast cancer (BRCA) remains one of the most common forms of cancer and is the most prominent driver of cancer-related death among women. The mechanistic basis for BRCA, however, remains incompletely understood. In particular, the relationships between driver mutations and signaling pathways in BRCA are poorly characterized, making it dicult to identify reliable clinical biomarkers that can be employed in diagnostic, therapeutic, or prognostic contexts. Methods: First, we downloaded publically available BRCA datasets (GSE45827, GSE42568, and GSE61304) from the Gene Expression Omnibus (GEO) database. We then compared gene expression proles between tumor and control tissues in these datasets using Venn diagrams and the GEO2R analytical tool. We further explore the functional relevance of BRCA-associated differentially expressed genes (DEGs) via functional and pathway enrichment analyses using the DAVID tool, and we then constructed a protein-protein interaction network incorporating DEGs of interest using the Search Tool for the Retrieval of Interacting Genes (STRING) database.
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Supplemental Information Proximity Interactions Among Centrosome
    Current Biology, Volume 24 Supplemental Information Proximity Interactions among Centrosome Components Identify Regulators of Centriole Duplication Elif Nur Firat-Karalar, Navin Rauniyar, John R. Yates III, and Tim Stearns Figure S1 A Myc Streptavidin -tubulin Merge Myc Streptavidin -tubulin Merge BirA*-PLK4 BirA*-CEP63 BirA*- CEP192 BirA*- CEP152 - BirA*-CCDC67 BirA* CEP152 CPAP BirA*- B C Streptavidin PCM1 Merge Myc-BirA* -CEP63 PCM1 -tubulin Merge BirA*- CEP63 DMSO - BirA* CEP63 nocodazole BirA*- CCDC67 Figure S2 A GFP – + – + GFP-CEP152 + – + – Myc-CDK5RAP2 + + + + (225 kDa) Myc-CDK5RAP2 (216 kDa) GFP-CEP152 (27 kDa) GFP Input (5%) IP: GFP B GFP-CEP152 truncation proteins Inputs (5%) IP: GFP kDa 1-7481-10441-1290218-1654749-16541045-16541-7481-10441-1290218-1654749-16541045-1654 250- Myc-CDK5RAP2 150- 150- 100- 75- GFP-CEP152 Figure S3 A B CEP63 – – + – – + GFP CCDC14 KIAA0753 Centrosome + – – + – – GFP-CCDC14 CEP152 binding binding binding targeting – + – – + – GFP-KIAA0753 GFP-KIAA0753 (140 kDa) 1-496 N M C 150- 100- GFP-CCDC14 (115 kDa) 1-424 N M – 136-496 M C – 50- CEP63 (63 kDa) 1-135 N – 37- GFP (27 kDa) 136-424 M – kDa 425-496 C – – Inputs (2%) IP: GFP C GFP-CEP63 truncation proteins D GFP-CEP63 truncation proteins Inputs (5%) IP: GFP Inputs (5%) IP: GFP kDa kDa 1-135136-424425-4961-424136-496FL Ctl 1-135136-424425-4961-424136-496FL Ctl 1-135136-424425-4961-424136-496FL Ctl 1-135136-424425-4961-424136-496FL Ctl Myc- 150- Myc- 100- CCDC14 KIAA0753 100- 100- 75- 75- GFP- GFP- 50- CEP63 50- CEP63 37- 37- Figure S4 A siCtl
    [Show full text]
  • Genetic and Genomic Analysis of Hyperlipidemia, Obesity and Diabetes Using (C57BL/6J × TALLYHO/Jngj) F2 Mice
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Nutrition Publications and Other Works Nutrition 12-19-2010 Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6J × TALLYHO/JngJ) F2 mice Taryn P. Stewart Marshall University Hyoung Y. Kim University of Tennessee - Knoxville, [email protected] Arnold M. Saxton University of Tennessee - Knoxville, [email protected] Jung H. Kim Marshall University Follow this and additional works at: https://trace.tennessee.edu/utk_nutrpubs Part of the Animal Sciences Commons, and the Nutrition Commons Recommended Citation BMC Genomics 2010, 11:713 doi:10.1186/1471-2164-11-713 This Article is brought to you for free and open access by the Nutrition at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Nutrition Publications and Other Works by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. Stewart et al. BMC Genomics 2010, 11:713 http://www.biomedcentral.com/1471-2164/11/713 RESEARCH ARTICLE Open Access Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6J × TALLYHO/JngJ) F2 mice Taryn P Stewart1, Hyoung Yon Kim2, Arnold M Saxton3, Jung Han Kim1* Abstract Background: Type 2 diabetes (T2D) is the most common form of diabetes in humans and is closely associated with dyslipidemia and obesity that magnifies the mortality and morbidity related to T2D. The genetic contribution to human T2D and related metabolic disorders is evident, and mostly follows polygenic inheritance. The TALLYHO/ JngJ (TH) mice are a polygenic model for T2D characterized by obesity, hyperinsulinemia, impaired glucose uptake and tolerance, hyperlipidemia, and hyperglycemia.
    [Show full text]
  • Screening and Identification of Hub Genes in Bladder Cancer by Bioinformatics Analysis and KIF11 Is a Potential Prognostic Biomarker
    ONCOLOGY LETTERS 21: 205, 2021 Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker XIAO‑CONG MO1,2*, ZI‑TONG ZHANG1,3*, MENG‑JIA SONG1,2, ZI‑QI ZHOU1,2, JIAN‑XIONG ZENG1,2, YU‑FEI DU1,2, FENG‑ZE SUN1,2, JIE‑YING YANG1,2, JUN‑YI HE1,2, YUE HUANG1,2, JIAN‑CHUAN XIA1,2 and DE‑SHENG WENG1,2 1State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine; 2Department of Biotherapy, Sun Yat‑Sen University Cancer Center; 3Department of Radiation Oncology, Sun Yat‑Sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China Received July 31, 2020; Accepted December 18, 2020 DOI: 10.3892/ol.2021.12466 Abstract. Bladder cancer (BC) is the ninth most common immunohistochemistry and western blotting. In summary, lethal malignancy worldwide. Great efforts have been devoted KIF11 was significantly upregulated in BC and might act as to clarify the pathogenesis of BC, but the underlying molecular a potential prognostic biomarker. The present identification mechanisms remain unclear. To screen for the genes associated of DEGs and hub genes in BC may provide novel insight for with the progression and carcinogenesis of BC, three datasets investigating the molecular mechanisms of BC. were obtained from the Gene Expression Omnibus. A total of 37 tumor and 16 non‑cancerous samples were analyzed to Introduction identify differentially expressed genes (DEGs). Subsequently, 141 genes were identified, including 55 upregulated and Bladder cancer (BC) is the ninth most common malignancy 86 downregulated genes. The protein‑protein interaction worldwide with substantial morbidity and mortality.
    [Show full text]
  • Supplementary Data
    SUPPLEMENTARY DATA A cyclin D1-dependent transcriptional program predicts clinical outcome in mantle cell lymphoma Santiago Demajo et al. 1 SUPPLEMENTARY DATA INDEX Supplementary Methods p. 3 Supplementary References p. 8 Supplementary Tables (S1 to S5) p. 9 Supplementary Figures (S1 to S15) p. 17 2 SUPPLEMENTARY METHODS Western blot, immunoprecipitation, and qRT-PCR Western blot (WB) analysis was performed as previously described (1), using cyclin D1 (Santa Cruz Biotechnology, sc-753, RRID:AB_2070433) and tubulin (Sigma-Aldrich, T5168, RRID:AB_477579) antibodies. Co-immunoprecipitation assays were performed as described before (2), using cyclin D1 antibody (Santa Cruz Biotechnology, sc-8396, RRID:AB_627344) or control IgG (Santa Cruz Biotechnology, sc-2025, RRID:AB_737182) followed by protein G- magnetic beads (Invitrogen) incubation and elution with Glycine 100mM pH=2.5. Co-IP experiments were performed within five weeks after cell thawing. Cyclin D1 (Santa Cruz Biotechnology, sc-753), E2F4 (Bethyl, A302-134A, RRID:AB_1720353), FOXM1 (Santa Cruz Biotechnology, sc-502, RRID:AB_631523), and CBP (Santa Cruz Biotechnology, sc-7300, RRID:AB_626817) antibodies were used for WB detection. In figure 1A and supplementary figure S2A, the same blot was probed with cyclin D1 and tubulin antibodies by cutting the membrane. In figure 2H, cyclin D1 and CBP blots correspond to the same membrane while E2F4 and FOXM1 blots correspond to an independent membrane. Image acquisition was performed with ImageQuant LAS 4000 mini (GE Healthcare). Image processing and quantification were performed with Multi Gauge software (Fujifilm). For qRT-PCR analysis, cDNA was generated from 1 µg RNA with qScript cDNA Synthesis kit (Quantabio). qRT–PCR reaction was performed using SYBR green (Roche).
    [Show full text]
  • CEP55 Polyclonal Antibody
    PRODUCT DATA SHEET Bioworld Technology,Inc. CEP55 polyclonal antibody Catalog: BS65295 Host: Rabbit Reactivity: Human BackGround: the digestive tract, bone marrow, lymph nodes, placenta, function:Plays a role in mitotic exit and cytokinesis. Not fetal heart and fetal spleen. Hardly detected in brain. required for microtubule nucleation. Recruits PDCD6IP Product: and TSG101 to midbody during cytokinesis.,PTM:There Liquid in PBS containing 50% glycerol, 0.5% BSA and is a hierachy of phosphorylation, where both Ser-425 and 0.02% sodium azide. Ser-428 are phosphorylated at the onset of mitosis, prior Molecular Weight: to Ser-436. Phosphorylation at Ser-425 and Ser-428 is ~ 54 kDa required for dissociation from the centrosome at the Swiss-Prot: G2/M boundary. Phosphorylation at the 3 sites, Ser-425, Q53EZ4 Ser-428 and Ser-436, is required for protein function at Purification&Purity: the final stages of cell division to complete cytokinesis The antibody was affinity-purified from rabbit antiserum successfully.,subcellular location:Present at the centro- by affinity-chromatography using epitope-specific im- somes at interphase. A small portion is associated prefer- munogen. entially with the mother centriole, whereas the majority Applications: localizes to the pericentriolar material. During mitosis, Western Blot: 1/500 - 1/2000. Immunohistochemistry: loss of affinity for the centrosome at the onset of pro- 1/100 - 1/300. ELISA: 1/40000. Not yet tested in other phase and diffusion throughout the cell. This dissociation applications. from the centrosome is phosphorylation-dependent. May Storage&Stability: remain localized at the centrosome during mitosis in cer- Store at 4°C short term.
    [Show full text]
  • Adhesion-Dependent Mechanisms Regulating Mitosis
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1523 Adhesion-dependent mechanisms regulating mitosis DEEPESH KUMAR GUPTA ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6206 ISBN 978-91-513-0531-8 UPPSALA urn:nbn:se:uu:diva-368422 2019 Dissertation presented at Uppsala University to be publicly examined in B42 Biomedical Center, Biomedical Center Husargatn 3, Uppsala, Friday, 1 February 2019 at 09:15 for the degree of Doctor of Philosophy (Faculty of Medicine). The examination will be conducted in English. Faculty examiner: Senior Scientist Kaisa Haglund (Oslo University Hospital). Abstract Gupta, D. K. 2019. Adhesion-dependent mechanisms regulating mitosis. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1523. 51 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0531-8. Integrin-mediated cell adhesion is required for normal cell cycle progression during G1-S transition and for the completion of cytokinesis. Cancer cells have ability to grow anchorage- independently, but the underlying mechanisms and the functional significance for cancer development are unclear. The current thesis describes new data on the adhesion-linked molecular mechanisms regulating cytokinesis and centrosomes. Non-adherent fibroblast failed in the last step of the cytokinesis process, the abscission. This was due to lack of CEP55-binding of ESCRT-III and its associated proteins to the midbody (MB) in the intercellular bridge (ICB), which in turn correlated with too early disappearance of PLK1 and the consequent premature CEP55 accumulation. Integrin-induced FAK activity was found to be an important upstream step in the regulation of PLK1 and cytokinetic abscission. Under prolonged suspension culture, the MB disappeared but septin filaments kept the ICB in the ingressed state.
    [Show full text]
  • Peripherally Generated Foxp3+ Regulatory T Cells Mediate the Immunomodulatory Effects of Ivig in Allergic Airways Disease
    Published February 20, 2017, doi:10.4049/jimmunol.1502361 The Journal of Immunology Peripherally Generated Foxp3+ Regulatory T Cells Mediate the Immunomodulatory Effects of IVIg in Allergic Airways Disease Amir H. Massoud,*,†,1 Gabriel N. Kaufman,* Di Xue,* Marianne Be´land,* Marieme Dembele,* Ciriaco A. Piccirillo,‡ Walid Mourad,† and Bruce D. Mazer* IVIg is widely used as an immunomodulatory therapy. We have recently demonstrated that IVIg protects against airway hyper- responsiveness (AHR) and inflammation in mouse models of allergic airways disease (AAD), associated with induction of Foxp3+ regulatory T cells (Treg). Using mice carrying a DTR/EGFP transgene under the control of the Foxp3 promoter (DEREG mice), we demonstrate in this study that IVIg generates a de novo population of peripheral Treg (pTreg) in the absence of endogenous Treg. IVIg-generated pTreg were sufficient for inhibition of OVA-induced AHR in an Ag-driven murine model of AAD. In the absence of endogenous Treg, IVIg failed to confer protection against AHR and airway inflammation. Adoptive transfer of purified IVIg-generated pTreg prior to Ag challenge effectively prevented airway inflammation and AHR in an Ag-specific manner. Microarray gene expression profiling of IVIg-generated pTreg revealed upregulation of genes associated with cell cycle, chroma- tin, cytoskeleton/motility, immunity, and apoptosis. These data demonstrate the importance of Treg in regulating AAD and show that IVIg-generated pTreg are necessary and sufficient for inhibition of allergen-induced AAD. The ability of IVIg to generate pure populations of highly Ag-specific pTreg represents a new avenue to study pTreg, the cross-talk between humoral and cellular immunity, and regulation of the inflammatory response to Ags.
    [Show full text]
  • Podocin Inactivation in Mature Kidneys Causes Focal Segmental Glomerulosclerosis and Nephrotic Syndrome
    BASIC RESEARCH www.jasn.org Podocin Inactivation in Mature Kidneys Causes Focal Segmental Glomerulosclerosis and Nephrotic Syndrome Ge´raldine Mollet,*† Julien Ratelade,*† Olivia Boyer,*†‡ Andrea Onetti Muda,*§ ʈ Ludivine Morisset,*† Tiphaine Aguirre Lavin,*† David Kitzis,*† Margaret J. Dallman, ʈ Laurence Bugeon, Norbert Hubner,¶ Marie-Claire Gubler,*† Corinne Antignac,*†** and Ernie L. Esquivel*† *INSERM, U574, Hoˆpital Necker-Enfants Malades, Paris, France; †Faculte´deMe´ decine Rene´ Descartes, Universite´ Paris Descartes, Paris, France; ‡Pediatric Nephrology Department and **Department of Genetics, Hoˆpital Necker- Enfants Malades, Assistance Publique-Hoˆpitaux de Paris, Paris, France; §Department of Pathology, Campus ʈ Biomedico University, Rome, Italy; Department of Biological Sciences, Imperial College London, London, England; and ¶Max-Delbruck Center for Molecular Medicine, Berlin, Germany ABSTRACT Podocin is a critical component of the glomerular slit diaphragm, and genetic mutations lead to both familial and sporadic forms of steroid-resistant nephrotic syndrome. In mice, constitutive absence of podocin leads to rapidly progressive renal disease characterized by mesangiolysis and/or mesangial sclerosis and nephrotic syndrome. Using established Cre-loxP technology, we inactivated podocin in the adult mouse kidney in a podocyte-specific manner. Progressive loss of podocin in the glomerulus recapitu- lated albuminuria, hypercholesterolemia, hypertension, and renal failure seen in nephrotic syndrome in humans. Lesions of FSGS appeared
    [Show full text]
  • The Genetic Program of Pancreatic Beta-Cell Replication in Vivo
    Page 1 of 65 Diabetes The genetic program of pancreatic beta-cell replication in vivo Agnes Klochendler1, Inbal Caspi2, Noa Corem1, Maya Moran3, Oriel Friedlich1, Sharona Elgavish4, Yuval Nevo4, Aharon Helman1, Benjamin Glaser5, Amir Eden3, Shalev Itzkovitz2, Yuval Dor1,* 1Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel 2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. 3Department of Cell and Developmental Biology, The Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel 4Info-CORE, Bioinformatics Unit of the I-CORE Computation Center, The Hebrew University and Hadassah, The Institute for Medical Research Israel- Canada, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel 5Endocrinology and Metabolism Service, Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel *Correspondence: [email protected] Running title: The genetic program of pancreatic β-cell replication 1 Diabetes Publish Ahead of Print, published online March 18, 2016 Diabetes Page 2 of 65 Abstract The molecular program underlying infrequent replication of pancreatic beta- cells remains largely inaccessible. Using transgenic mice expressing GFP in cycling cells we sorted live, replicating beta-cells and determined their transcriptome. Replicating beta-cells upregulate hundreds of proliferation- related genes, along with many novel putative cell cycle components. Strikingly, genes involved in beta-cell functions, namely glucose sensing and insulin secretion were repressed. Further studies using single molecule RNA in situ hybridization revealed that in fact, replicating beta-cells double the amount of RNA for most genes, but this upregulation excludes genes involved in beta-cell function.
    [Show full text]